• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双氯芬酸(扶他林)治疗骨关节炎:与萘普生的双盲对照研究

Diclofenac (Voltaren) for the treatment of osteo-arthrosis: a double-blind comparison with naproxen.

作者信息

Siraux P

出版信息

J Int Med Res. 1977;5(3):169-74. doi: 10.1177/030006057700500305.

DOI:10.1177/030006057700500305
PMID:330288
Abstract

A double-blind, between-patient, comparative trial of diclofenac (Voltaren) and naproxen was carried out in 30 patients suffering from osteo-arthrosis of the hip or the knee. The drugs were given twice daily, morning and evening, during a period of two weeks. The daily dose was 100 mg for Voltaren and 500 mg for naproxen. The results indicate that Voltaren brought relief of pain and stiffness in a greater number of patients than did naproxen. The same finding was made regarding the influence on the range of joint movements, the difference reaching statistical significance. Voltaren appeared also to be better tolerated since the number of patients reporting side-effects was smaller and the complaints of less severity.

摘要

对30例髋或膝骨关节炎患者进行了双盲、患者间比较试验,比较双氯芬酸(扶他林)和萘普生。药物在两周内每天早晚各服用一次。扶他林的日剂量为100毫克,萘普生为500毫克。结果表明,与萘普生相比,扶他林能使更多患者的疼痛和僵硬得到缓解。在对关节活动范围的影响方面也有相同的发现,差异具有统计学意义。扶他林的耐受性似乎也更好,因为报告副作用的患者数量较少,且症状较轻。

相似文献

1
Diclofenac (Voltaren) for the treatment of osteo-arthrosis: a double-blind comparison with naproxen.双氯芬酸(扶他林)治疗骨关节炎:与萘普生的双盲对照研究
J Int Med Res. 1977;5(3):169-74. doi: 10.1177/030006057700500305.
2
[Comparative double-blind trial of diclophenac-sodium and naproxen in hip arthrosis].双氯芬酸钠与萘普生治疗髋关节炎的比较双盲试验
Reumatizam. 1981;28(6):193-6.
3
Diclofenac sodium (Voltaren) and naproxen in the treatment of rheumatoid arthritis: a comparative double-blind study.
Scand J Rheumatol Suppl. 1978(22):57-62. doi: 10.3109/03009747809097218.
4
[Long-term comparative study: diclofenac (voltaren) and naproxen (proxen) in arthritis].[长期对比研究:双氯芬酸(扶他林)与萘普生(甲氧萘丙酸)治疗关节炎]
Schweiz Med Wochenschr. 1978 Mar 4;108(9):349-53.
5
[Comparative efficacy of voltaren and naproxen in rheumatoid arthritis (double-blind trial)].
Ter Arkh. 1981;53(7):111-4.
6
A Double-blind comparison of naproxen against indometacin in osteoarthrosis.
Arzneimittelforschung. 1975 Feb;25(2A):302-4.
7
A comparison of naproxen and diclofenac sodium in the treatment of osteoarthritis in elderly patients.萘普生与双氯芬酸钠治疗老年骨关节炎的比较。
Br J Clin Pract. 1985 Jul;39(7):276-81.
8
A double-blind multicentre comparison of diclofenac sodium and naproxen in osteoarthrosis of the hip.双氯芬酸钠与萘普生治疗髋关节骨关节炎的双盲多中心比较
Scand J Rheumatol Suppl. 1978(22):63-8. doi: 10.3109/03009747809097219.
9
[Comparison of the analgesic and anti-inflammatory effects of diclofenac, sulindac and naproxen. Multicentric double blind study].
Prensa Med Mex. 1979 Jan-Feb;43(1-2):38-40.
10
A comparative study of naproxen with diclofenac sodium in osteoarthrosis of the knees.萘普生与双氯芬酸钠治疗膝骨关节炎的对比研究。
Rheumatol Rehabil. 1982 Aug;21(3):167-70. doi: 10.1093/rheumatology/21.3.167.

引用本文的文献

1
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.双氯芬酸钠:其药理特性及在风湿性疾病和各种原因引起的疼痛中的治疗应用综述
Drugs. 1980 Jul;20(1):24-48. doi: 10.2165/00003495-198020010-00002.
2
Outcome measurement in osteoarthritis clinical trials: the case for standardisation.骨关节炎临床试验中的疗效评估:标准化的必要性
Clin Rheumatol. 1984 Sep;3(3):293-303. doi: 10.1007/BF02032334.
3
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
双氯芬酸钠。对其药效学和药代动力学特性以及治疗效果的重新评估。
Drugs. 1988 Mar;35(3):244-85. doi: 10.2165/00003495-198835030-00004.
4
Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.萘普生最新进展:对其药理特性、治疗效果以及在风湿性疾病和疼痛状态中的应用的综述。
Drugs. 1979 Oct;18(4):241-77. doi: 10.2165/00003495-197918040-00001.